Skip to content

Clinical trials

Phase 2 Brain Neoplasms trials in Australia

Search ClinicalTrials.gov registrations by keyword, then narrow by condition, phase, status, country and start year.

Filters: Condition: Brain Neoplasms Phase: Phase 2 Country / region: Australia Clear all

24 trials match Source: ClinicalTrials.gov registrations

Trials started per year

By phase, 2000 to 2026.

Trials started per year
CategoryTrials
20031
20041
20051
20061
20111
20131
20143
20154
20161
20171
20193
20242
20251

Status

Trials by registry status. Select a bar to filter.

Trials by status
CategoryTrials
Completed13
Active, not recruiting4
Recruiting4
Terminated3

Top lead sponsors

A sponsor with a page on Pharma Observatory links to it.

Top lead sponsors
CategoryTrials
Children's Oncology Group5
Novartis Pharmaceuticals3
Eli Lilly and Company2
GlaxoSmithKline2
Melanoma Institute Australia2
AbbVie1
Apollomics Inc.1
Australian & New Zealand Children's Haematology/Oncology Group1
Eastern Cooperative Oncology Group1
Hoffmann-La Roche1

Top conditions

MeSH conditions the trials were registered with, not their broader categories. A condition with a page on Pharma Observatory links to it.

Top conditions
CategoryTrials
Brain Neoplasms24
Melanoma9
Central Nervous System Neoplasms5
Breast Neoplasms4
Glioblastoma4
Astrocytoma3
Carcinoma, Non-Small-Cell Lung3
Glioma3
Carcinoma, Renal Cell2
Diffuse Intrinsic Pontine Glioma2

Trials

Showing 1 to 24 of 24. Each trial links to its page on Pharma Observatory.

Recently changed trials

Changes observed in the last 7 days, newest first, site-count changes left out. Source: ClinicalTrials.gov.

No changes to these trials in the last 7 days.

Go deeper on Pharma Observatory

Pharma Observatory connects clinical trials, sponsors, sites and investigators in one searchable platform.